Watch Desk posted an update
Novartis chief executive Vasant Narasimhan says AI could cut drug development from 12 years to eight and improve the odds of bringing new medicines to market.
Why it mattersIn a Bloomberg interview, he said AI is already helping the company analyse data, identify drug candidates and speed up clinical trials. Those are his claims about Novartis’s work, not evidence here that development timelines have already shortened. Four years would be a considerable gain. The question is whether AI can deliver it once medicines still have to pass through the rather stubborn business of clinical trials.
Discuss: If AI helps discover or test medicines faster, what evidence should companies show before claiming it has shortened the path to a new treatment?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.